| Name | Title | Contact Details |
|---|
Jacobi Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Jacobi Medical Center is based in Bronx, NY. You can find more information on Jacobi Medical Center at www.nbhn.net
Physical Rehabilitation Network (PRN) was founded in 1991 to assist physical therapists in developing and operating their own practice without carrying the burden of business administration and back office functions. In this capacity our partners can focus on what they do best - providing excellence in patient care! PRN has a fierce commitment to our therapist partners with proven revenue cycle management, personalized human resources, regional business development and contract opportunities. PRN is the most prominent network of independently operated physical & hand rehabilitation centers in the western United States. After starting out in southern California with one practice, PRN presently serves over 120 centers in nine states.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.